Perineal pyoderma gangrenosum in a girl treated with adalimumab after infliximab failure Pioderma gangrenoso perineal en una niña tratado con adalimumab tras fallo a infliximab

Perineal pyoderma gangrenosum in a girl treated with adalimumab after infliximab failure Pioderma gangrenoso perineal en una niña tratado con adalimumab tras fallo a infliximab

Bibliographic Details
Main Authors:	Luisa Castro-Laria, Federico Argüelles-Arias, Manuel García-Martín, Susana Jiménez-Contreras, Federico Argüelles-Martín, Juan Manuel Herrerías-Gutiérrez
Format:	Article
Language:	English
Published:	Aran Ediciones 2011-08-01
Series:	Revista Espanola de Enfermedades Digestivas
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082011000800015

Similar Items

Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab Pioderma gangrenoso asociado a colitis ulcerosa: respuesta a infliximab
by: A. López San Román, et al.
Published: (2004-06-01)

Pioderma gangrenoso: apresentação atípica Pyoderma gangrenosum: an atypical presentation
by: Juliana Cristina Silva Fraga, et al.
Published: (2006-10-01)

Extensive Refractory Perineal Pyoderma Gangrenosum Treated with Infliximab, Fecal Diversion, and Negative-Pressure Wound Therapy
by: Mafalda Sousa, et al.
Published: (2019-09-01)

Pioderma gangrenoso e lúpus eritematoso sistêmico Pyoderma gangrenosum and systemic lupus erythematosus
by: Claudine J. C. Burkieviecz, et al.
Published: (2007-08-01)

Pyoderma gangrenosum with extensive perianal involvement Pioderma gangrenoso con extensa afectación perianal
by: Marlén Alvite-Canosa, et al.
Published: (2012-02-01)

Pioderma gangrenoso bolhoso e síndrome mielodisplásica Bullous pyoderma gangrenosum and myelodysplastic syndrome
by: Mariana Dias Batista, et al.
Published: (2006-10-01)

Pioderma Gangrenoso: um Artigo de Revisão Pyoderma Gangrenosum: a Review Article
by: Clóvis Luíz Konopka, et al.
Published: (2013-03-01)

Pyoderma gangrenosum and ulcerative colitis in the tropics Pioderma gangrenoso e colite ulcerativa nos trópicos
by: Olatunji B. Alese, et al.
Published: (2008-12-01)

Pioderma gangrenoso: um desafio para o reumatologista Pyoderma gangrenosum: a challenge to the rheumatologist
by: Luciano Ferreira Coelho, et al.
Published: (2009-06-01)

Infliximab como opción terapéutica en pioderma gangrenoso mamario bilateral postquirúrgico refractario
by: I. Castaño-González, et al.
Published: (2015-03-01)

Pioderma gangrenoso tras una polectomía
by: B. Occhi Gómez, et al.
Published: (2016-05-01)

Crohn’s Disease Associated Pyoderma Gangrenosum Treated with Adalimumab
by: Despoina Kakagia, et al.
Published: (2012-03-01)

Perineal pyoderma gangrenosum in pregnancy: A case report
by: Takako Ohmaru-Nakanishi, et al.
Published: (2019-04-01)

Oxigenoterapia hiperbárica como tratamento adjuvante do pioderma gangrenoso Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum
by: Wilson Albieri Vieira, et al.
Published: (2011-12-01)

Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone
by: Julia D. Stiegler, MD, et al.
Published: (2017-09-01)

Pioderma gangrenoso e artrite reumatóide: relato de caso Pyoderma gangrenosum and rheumatoid arthritis: case report
by: Izelda Maria Carvalho Costa, et al.
Published: (2005-02-01)

Pioderma Gangrenoso: apresentação clínica de difícil diagnóstico Pyoderma gangrenosum: a clinical manifestation of difficult diagnosis
by: Mônica Santos, et al.
Published: (2011-02-01)

Pioderma granulomatoso superficial: relato de caso de variante rara do pioderma gangrenoso Superficial granulomatous pyoderma: report of a case of an uncommon variant of pyoderma gangrenosum
by: Alceu Luiz Camargo Villela Berbert, et al.
Published: (2009-07-01)

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
by: Salehzadeh F, et al.
Published: (2019-05-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)

Fatal outcome of pyoderma gangrenosum with multiple organ involvement and partially responding to Infliximab
by: Drinda Stefan, et al.
Published: (2006-09-01)

Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement
by: Paul A. Leiphart, BA, et al.
Published: (2018-01-01)

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
by: Jong Pil Im
Published: (2017-04-01)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
by: Assasi Nazila, et al.
Published: (2009-12-01)

Pyoderma gangrenosum and chronic granulomatous disease treated with adalimumab: Case-based review
by: Samar Tharwat, et al.
Published: (2021-04-01)

Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
by: Song Christine H, et al.
Published: (2012-11-01)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
by: Henry Alistair I, et al.
Published: (2011-11-01)

Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
by: Carlos Henrique Marques dos Santos
Published: (2014-07-01)

Efficacy of adalimumab in patients with crohn's disease and failure to infliximab therapy: a clinical series Eficacia de Adalimumab en pacientes con enfermedad de Crohn y fracaso previo a la terapia con Infliximab: resultados de una serie clínica
by: Patricia Cordero-Ruiz, et al.
Published: (2011-06-01)

Pioderma Gangrenoso em Lactente
by: Michelle Soares Martins, et al.
Published: (2016-08-01)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.
by: Monika Hebeisen, et al.
Published: (2019-01-01)

Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn’s disease
by: Arne Carlsen, et al.
Published: (2018-03-01)

Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn's disease
by: Carlos Taxonera, et al.

Synchronous pyoderma gangrenosum and inflammatory bowel disease, healing after total proctocolectomy Pioderma gangrenoso associado a doença inflamatória intestinal, com resolução após proctocolectomia total
by: Pedro Andrade, et al.
Published: (2012-08-01)

Long-Term Clinical Remission in Biologically Naïve Crohn’s Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab
by: Tsutomu Mizoshita, et al.
Published: (2016-06-01)

PIODERMA GANGRENOSO – RELATO DE CASO
by: Marina Nahas Dafico Bernardes, et al.
Published: (2016-06-01)

Pioderma gangrenoso: relato de caso
by: Marilho Tadeu Dornelas, et al.
Published: (2009-03-01)

A systematic review on infliximab and adalimumab drug monitoring: levels, clinical outcomes and assays
by: Ana Filipa da Silva Ferreira
Published: (2019)

The Impact of Introducing Successive Biosimilars on Changes in Prices of Adalimumab, Infliximab, and Trastuzumab—Polish Experiences
by: Olga Barszczewska, et al.
Published: (2021-06-01)

Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay
by: Konstantinos Papamichael, et al.
Published: (2020-09-01)